Deal Terms
Calculator
Data-driven estimates for upfront payments, milestones, and royalties
for oncology licensing and M&A transactions
How It Works
Get deal term estimates in three simple steps
Enter Asset Details
Select development phase, modality, indication, and other key parameters for your oncology asset.
Analyze Market Data
Our algorithm processes your inputs against publicly available deal benchmarks and market data.
Get Deal Estimates
Receive instant estimates for upfront payments, milestones, royalties, and total deal value.
Built for Life Sciences Professionals
Whether you're a biotech founder, BD executive, or investor, get instant benchmarks for your deals
Data-Driven Benchmarks
Estimates based on publicly available deal terms from SEC filings, press releases, and industry reports.
Customizable Analysis
Adjust for development phase, modality, indication type, and competitive positioning for relevant estimates.
Instant Results
Get immediate estimates for upfront payments, development milestones, regulatory milestones, and royalties.
Trusted by Life Sciences Professionals
Powering deal analysis for biotech and pharma
Choose Your Plan
Get instant deal benchmarks for free, or unlock comprehensive insights with Pro
Free
Perfect for initial exploration
- Basic deal term estimates
- Upfront & total value ranges
- All phases & modalities
- 2 partner matches (names only)
- Full milestone breakdowns
- Royalty rate analysis
- Partner profiles & deal history
- PDF reports
Pro
Complete deal intelligence
- Everything in Free, plus:
- 5 partner matches with full profiles
- Partner deal history & activity signals
- Therapeutic focus & patent cliff data
- Full milestone breakdowns
- Royalty rate analysis
- Downloadable PDF reports
- Unlimited calculations
Need enterprise features or custom analysis?
Get tailored solutions for your organization
Ambrosia Ventures
A boutique strategy and M&A advisory firm specializing in life sciences. We help biotech companies, pharmaceutical corporate development teams, and investors navigate licensing deals, M&A transactions, and strategic partnerships.